 of stenosis is ⱖ20%, screening reduced risk
of stroke in a cost-effective manner, with intermediate
prevalence of between 5% and 20%: screening reduced the
risk of stroke in a cost-effective manner in some studies;
however, the benefit was usually marginal and was lost if
complications of the intervention ⬎5%. With a prevalence
of ⬍5%, screening has not been shown to reduce the risk of
stroke